Protease: APEX 10-7082 CENTURY 7-152 EB 2-14511 EB 5-16901 EB 8-14861 EB 9-14191 EXCLZYME EXCLZYME EN GLOBAL 8-658 HFN 7-7113 META 10-185 MHNHEM 2-158 PEPZYME AG PROTEASE - 1000 PROTEASE 250,000 SEB PRO FP 500 SEB PRO FP 600 SYS 7-7742 UT 11-216 N VEGPANZYME 1213 VEGPANZYME PLUS
Recalled by Specialty Enzymes & Biotechnologies on Oct 3, 2013
Reason for Recall
Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol.
Product Description
Protease: APEX 10-7082 CENTURY 7-152 EB 2-14511 EB 5-16901 EB 8-14861 EB 9-14191 EXCLZYME EXCLZYME EN GLOBAL 8-658 HFN 7-7113 META 10-185 MHNHEM 2-158 PEPZYME AG PROTEASE - 1000 PROTEASE 250,000 SEB PRO FP 500 SEB PRO FP 600 SYS 7-7742 UT 11-216 N VEGPANZYME 1213 VEGPANZYME PLUS
Distribution
Nationwide in US and worldwide to: Australia, Canada, Malaysia, Taiwan, Italy
What Should You Do?
- 1.Check your kitchen for this product immediately.
- 2.Do not consume the recalled product.
- 3.Return the product to where you bought it for a full refund, or throw it away.
- 4.If you have experienced any health issues, contact your healthcare provider.
Browse Related Recalls
Terms Explained
- Class II Recall — learn what this means in food safety
- FDA Food Recall — learn what this means in food safety
The this entity record above pulls directly from the FDA openFDA enforcement-report API. What follows is the per-entity context — how this entity sits in the broader U.S. FDA food, drug, and device recalls distribution and which underlying factors drive the headline numbers.
Every number on this page links back to the FDA openFDA enforcement-report API; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.
Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. consumer-product recalls. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.
Source: FDA Recalls, Market Withdrawals and Safety Alerts, 2026.